EP Patent

EP0124495A2 — Omeprazole salts

Assigned to Hassle AB · Expires 1984-11-07 · 42y expired

What this patent protects

Novel salts of omeprazole with Li<sup>+</sup>, Na<sup>+</sup>, K<sup>+</sup>, Mg<sup>2+</sup>, Ca2+, Ti<sup>4+</sup>, N<sup>+</sup>(R<sup>1</sup>)<sub>4</sub&g…

USPTO Abstract

Novel salts of omeprazole with Li<sup>+</sup>, Na<sup>+</sup>, K<sup>+</sup>, Mg<sup>2+</sup>, Ca2+, Ti<sup>4+</sup>, N<sup>+</sup>(R<sup>1</sup>)<sub>4</sub>as cation; processes for their preparation thereof, pharmaceutical compositions containing such salts and their use in medicine.

Drugs covered by this patent

Patent Metadata

Patent number
EP0124495A2
Jurisdiction
EP
Classification
—
Expires
1984-11-07
Drug substance claim
No
Drug product claim
No
Assignee
Hassle AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.